1. Introduction {#s0005}
===============

The new era in diabetes treatment facilitates the rapid green synthesis of multifunctional, biocompatible, and eco-friendly metal colloidal nanoparticles (Nps), as effective nanomedicine against the emerging threat of diabetes mellitus (DM), and as a result the harsh environmental impact of its associated complications ([@b0020], [@b0140]). Worldwide, DM is estimated to reach 592 million people by the year 2035, with a prevalence of 8.3% ([@b0100]). The increased prevalence is owing to five main influences, modernization of lifestyle, obesity, aged population, ethnicity, and unavoidable genetic predisposition ([@b0115]). By convention, DM is classified into two main types, Type I DM (IDDM, insulin dependent diabetes mellitus), treated with insulin replacement therapy, whilst diet, lifestyle modifications and oral antidiabetic drugs are considered the foundation for the treatment and management of Type II DM (NIDDM, non-insulin dependent diabetes mellitus). Despite the popularity of insulin and oral antihyperglycaemic drugs, epidemiological studies and clinical trials strongly support the notion that the prolonged use of such agents fail to prevent the progression of long-term complications such as, diabetic retinopathy, neuropathy, nephropathy, foot infections, atherosclerosis and other associated cardiovascular events, including hypertension, obesity, dyslipidemia, and hypercoagulability ([@b0030], [@b0260]). The main drawback of insulin is that they are associated with fear of painful injections, poor patient compliance, complex to use and prescribe, potential dosing errors, diabetic ketoacidosis, local tissue necrosis, infection, nerve damage, whilst cost and iatrogenic hypoglycaemia will continue to be an important limiting factor ([@b0200], [@b0060]). Research indicates that most oral antihyperglycaemic agents cannot maintain normal levels of blood glucose for an extended period of time, especially in the elderly ([@b0030]) and gestational diabetes during pregnancy ([@b0315]). These agents also pose risks of hypoglycaemia, cardiovascular diseases, weight gain, gastrointestinal (GI) disturbances (severe lactic acidosis), liver injury, renal complications, and hypersensitivity reactions ([@b0265]), therefore, making the development of effective antidiabetic agents as one of the world's top public health priorities.

Applications of engineered Ag, Au, Fe, Pt, Zn, etc. and metal oxide Nps have evolved positively, influencing medicine, science, and many new agro-food industries ([@b0045]). Nps offer unique self-assembly properties, size dependent crystalline structure (1--100 nm), greater surface to volume ratios, stability, specificity, drug encapsulation, surface structure and biocompatibility due to their material composition ([@b0330], [@b0065]). Thus, nanomedicine facilitates the production and application of devices or materials to interact with the human body at a molecular level with a high degree of specificity, this can potentially be translated into targeted cellular and tissue-specific clinical applications, designed to achieve maximal therapeutic efficacy with minimal to no side effects ([@b0280]). The success rate of nanomedicine can be observed in its attempts for treatment of lung cancer ([@b0085]), acute myeloid leukaemia (AML) ([@b0105]), colon cancer ([@b0240]), HIV-1 ([@b0080]), plasmodial ([@b0230]), fungal, and bacterial infections ([@b0185]).

The metal Ag maintains its effective antimicrobial status, however restricted to topical use whilst, colloidal AgNps is currently promoted as an alternative medicine treatment for a vast number of non-communicable diseases including DM ([@b0335]). The reasons include its unique and tunable surface plasmon resonance (SPR), decreased side effects, non-toxicity, and ease of biodegradability that seem to possess the ability to decrease blood glucose, lipid levels, inflammation, and increase serum insulin levels and expression using *in vitro* and *in vivo* research methods ([@b0020]). However, the pharmacokinetic implications of these Nps for treatment of different types of diseases require more detailed investigation.

A major component of using phytotherapy such as that belonging to *Ocimum basilicum* (Sweet basil) and *Ocimum sanctum*/*Ocimum tenuiflorum* (Holy basil/Tulsi) from the family Lamiaceae ([@b0145]) is due to its dynamic effect on the human body, that appears to elicit the same response to currently available antihyperglycaemic drugs, with the exclusion of negative side effects. However, due to their vast bioactive chemical constituents such as, polyphenols, flavonoids, alkaloids, terpenoids, steroids, and glycosides, that synergistically coexist, limits our understanding of their full therapeutic effectiveness ([@b0145], [@b0120]). To address this, functionalizing green AgNps derived from these pharmacologically important plants is a viable option to use for preparation of colloidal drugs, thus enhance the nature of well-known medicinal plants in combination with the different specificities of nanotherapy ([@b0035]). Indeed, it is expected that the enhanced biocatalytic activity of AgNps which contains *in situ* generated capping agents synthesized from the leaf of *O. basilicum*, *O. sanctum* and in combination, may have the capacity to serve as dual antidiabetic and antimicrobial agents.

2. Materials and methods {#s0010}
========================

2.1. Chemicals and materials {#s0015}
----------------------------

Fresh leaves of *O. basilicum* and *O. sanctum* were collected from Tropical Garden Nursery in KwaZulu Natal, South Africa (SA). The plants were botanically identified in the KwaZulu Natal (KZN) Herbarium Durban, SA by Mr. M.A. Ngwenya and voucher specimens were deposited (Voucher 1: *O. basilicum* L., Det: Malapermal, V., NH0137401; Voucher 2: *O. tenuiflorum* (*sanctum*) L., Det: Malapermal, V., NH0137400) and the solvents absolute ethanol obtained from Merck (SA) was of analytical grade. Silver nitrate (AgNO~3~, ACS reagent), type Vi-B from Porcine α-amylase; *Bacillus stearothermophilus* α-glucosidase; potato starch; p-nitrophenyl-α-[d]{.smallcaps}-glucopyranoside (pNPG); 3,5-dinitrosalicylic acid and sodium potassium tartrate were purchased from Sigma--Aldrich Chemicals (SA) and Acarbose, Glucobay® 50 was purchased from a local pharmacy. Gentamycin 10 μg and Vancomycin 30 μg discs were purchased from Davies Diagnostics (SA).

2.2. Preparation of crude extracts for enzyme analysis {#s0020}
------------------------------------------------------

### 2.2.1. *O. basilicum* and *O. sanctum* crude extracts {#s0025}

*O. basilicum* and *O. sanctum* crude extracts for the α-amylase and α-glucosidase analysis were prepared by using 10 g each of leaves and flowers that were cleaned, weighed and crushed in a glass beaker. To the respective plant parts 100 ml of 60% EtOH, 70% EtOH and distilled water, respectively were added and left to stand for 24 h. The extract was filtered into a conical flask using a mutton cloth and Whatman No. 1 filter paper. The resultant extract had 10% concentration and was used as a stock solution ([@b0005]).

### 2.2.2. *O. sanctum* ethanol based crude extracts {#s0030}

For the α-glucosidase analysis additional extracts for *O. sanctum* leaf parts were used to prepare homoeopathic 150 g mother tinctures. The method used was in accordance with method 2a of the [@b0090]; the plant parts were dispensed in 43% m/m (60% v/v EtOH) alcohol and were prepared by maceration. The mixture was then left to stand for not less than 10 days, before eventually being expressed and filtered using mutton cloth and Whatman No. 1 filter paper ([@b0090]).

### 2.2.3. *O. sanctum* aqueous based crude extracts {#s0035}

In addition, 100 g fresh leaves of *O. sanctum* were homogenized with 10 ml of sterile distilled water, using a mortar and pestle, so that a 100% solution was obtained. This was filtered through a mutton cloth and Whatman No. 1 filter paper ([@b0150]).

For all the crude extracts the solvents were allowed to evaporate using a rotary evaporator (Heidolph Rotavac) at a temperature of 40--50 °C until a semi solid sticky mass was obtained. All the extracts were finally freeze dried using a freeze-dryer (Virtis).

2.3. Biosynthesis of AgNps {#s0040}
--------------------------

The *O. basilicum* and *O. sanctum* leaf extract was prepared by taking 10 g of thoroughly washed and finely cut leaves in an Erlenmeyer flask in combination with 100 ml of sterile deionised water, the mixture was boiled for 10 min, and then cooled. Briefly, 10 ml of the leaf extract was added drop wise (2 ml) to 45 ml of 1 mM AgNO~3~ solution and vigorously stirred with the aid of a magnetic stirrer, until the first colour change (brown solution) that indicated the reduction of Ag^+^ ions after a few minutes. The formation of AgNps was monitored for a period of 36 h. The method was repeated in combination (*O. sanctum* plus *O. basilicum*) to obtain the extract under the above mentioned standard conditions to evaluate the synergistic effect.

### 2.3.1. Characterization {#s0045}

The AgNps were characterized using UV--Vis spectrophotometer (Varian Cary-50 UV spectrophotometer) linked to a TCC-240A Shimadzu heating vessel temperature controlled cell holder) in the range of 300--700 nm. The particle size and shape were obtained by conducting TEM studies, by placing 1 μl of the samples on formvar coated grids, air dried and viewed at 100 kV (JEOL 1010 TEM using a Megaview III camera and iTEM software). For the particles' images and elemental analysis studies, the samples were prepared by fixing the powder particles to a microscope holder, using conducting carbon tape; and subjected to Carl Zeiss, model EVO HD 15 scanning electron microscope with EDX detector, Oxford Instruments. FTIR spectra were recorded for the green aqueous leaf extract and AgNps with Bruker Alpha FTIR Spectrophotometer. Differential Light Scattering *Malvern Zetasizer Nano ZS* (*Malvern* Instruments Ltd., UK) Merck 2423 instrument was used to measure particle size and zeta potential.

2.4. Antidiabetic screening {#s0050}
---------------------------

### 2.4.1. α-amylase inhibitory test {#s0055}

The effect of time and dose on the inhibitory activity of α-amylase (Type Vi-B from Porcine pancreas) was investigated by methods described by [@b0015], [@b0025], respectively.1.Time-dependent method: Briefly, 120 μl of the test sample (3 mg/ml for AgNps and 2 mg/ml for crude extracts) was taken, 480 μl of distilled water and 1200 μl of the potato starch (0.5% w/v primed in 20 mM phosphate buffer) were mixed, 600 μl α-amylase (0.05 g of α-amylase prepared in 100 ml ice-cold distilled water) was added to the reaction mixture and incubated at 25 ± 2 °C for 3 min. After every 1 min, 200 μl was removed from the reaction mixture and 100 μl of DNS colour reagent (96 mM 3,5-dinitrosalicylic acid, 12 g sodium potassium tartrate in 8 ml of 2 M NaOH) was added. The reaction mixture was heated for 15 min at 85 ± 2 °C. After cooling, 900 μl of distilled water was added to the mixture and mixed thoroughly. The optical density (OD) was recorded at 540 nm against the blank. The blank contained 600 μl of distilled water instead of enzyme solution and for the control, test samples were replaced with 120 μl and thus represented maximum enzymatic activity. For *t* = 0 min, a separate experiment was performed, by adding the samples to the DNS solution immediately after addition of the enzyme solution. The assay was performed in triplicate. For calculating the percentage inhibition, the following equations were used. Firstly, the net absorbance (A) using Eq. [(1)](#e0005){ref-type="disp-formula"} due to maltose generated was calculated. Secondly, from the net absorbance obtained, the percentage (w/v) of maltose generated was calculated from the Eq. [(2)](#e0010){ref-type="disp-formula"} obtained from the equation in the maltose standard calibration curve (0--2% w/v). Finally, the percentage inhibition was calculated at *t* = 3 min using Eq. [(3)](#e0015){ref-type="disp-formula"} and 50% inhibition or higher was taken as significant (*p* \< 0.05).$$\text{Absorbance\ at}\mspace{6mu} 540\ \text{nm\ control\ or\ plant\ extract} = A_{540\text{nm}}\text{Test} - A_{540\text{nm}}\text{Blank}$$$$\%\mspace{6mu}\text{Reaction} = \frac{\text{Mean\ maltose\ in\ sample}}{\text{Mean\ maltose\ in\ control}} \times 100$$$$\%\mspace{6mu}\text{Inhibition} = 100 - \%\mspace{6mu}\text{Reaction}$$2.Dose-dependent method: briefly, 1 ml α-amylase (0.5 unit/ml) primed in 20 mM phosphate buffer (pH 6.9) was pre-incubated for 30 min with a 1 ml test solution (0.0002--2 mg/ml). The reaction was started by the addition of 1 ml potato starch (0.5% w/v, prepared by dissolving in 100 ml distilled water). The reaction mixture was incubated at 25 ± 2 °C for 30 min. Finally, the catalytic reaction was terminated with the addition of 1 ml DNS reagent. The reaction mixture was heated for 15 min at 85 ± 2 °C in a water bath. The tubes were cooled to room temperature and 9 ml of distilled water was added. Individual blanks were prepared for amending the background absorbance; colour reagent was added prior to the addition of starch solution and placed into the water bath. For control incubations all procedures were the same except that the AgNps extracts was replaced by 1 ml distilled water. The OD was recorded at 540 nm. Antidiabetic medicine acarbose in concentrations of 0.016--1 mg/ml was used as positive control. The assay was performed in triplicate and the mean absorbance was used to calculate percentage of α-amylase inhibition:$$I_{\alpha - \text{Amylase}}\% = \frac{(\Delta A540\ \text{nm\ Control} - \Delta A540\ \text{nm\ Sample})}{\Delta A540\ \text{nm\ Control}} \times 100$$

### 2.4.2. α-Glucosidase inhibitory test {#s0060}

The α-glucosidase inhibitory test (*I*~α-Glucosidase~) was performed by preparing, 0.1 ml of 0.5 unit/ml α-glucosidase prepared in ice-cold distilled water that was pre-incubated with 0.1 ml of test samples (range of 0.2 mg/ml and 0.3 mg/ml) for 5 min. 0.1 ml of the substrate pNPG 3 mM prepared in 0.01 M phosphate buffer (pH 6.9) was added to start the reaction. After further incubation at 37 ± 2 °C for 30 min, the reaction was stopped by adding 1.5 ml of 0.1 M sodium carbonate. Individual blanks were prepared for amending the background absorbance; buffer was added instead of the enzyme. For the control incubations all procedures were the same except that the test extract was replaced by buffer. Antidiabetic medicine acarbose in concentrations of 0.00001--1 mg/ml was used as positive control. Enzymatic activity was quantified by measuring the OD at 405 nm. Percentage α-glucosidase activity is calculated by using the following equation ([@b0225]):$$I_{\alpha - \text{Glucosidase}}\% = \frac{(\Delta A540\ \text{nm\ Control} - \Delta A540\ \text{nm\ Sample})}{\Delta A540\ \text{nm\ Control}} \times 100$$

### 2.4.3. IC~50~ values of active AgNps extracts {#s0065}

The potency of AgNps extracts as inhibitors of enzyme catalytic activities of both α-amylase and α-glucosidase was assessed in terms of their IC~50~ values (inhibitor concentration that reduces enzyme activity by 50%) ([@b0055], [@b0205]). Briefly, aliquots of α-amylase and α-glucosidase enzymes were pre-incubated with increasing concentrations of the AgNps extracts and acarbose. Catalytic reactions were started, terminated and enzyme activities determined as mentioned above. The activity of fractions and compounds was assessed by plotting percentage inhibition against a range of concentrations and determining the inhibitory concentration 50% (IC~50~) value by interpolation of a cubic spline dose--response curve using GraphPad Prism® 5.03 software.

### 2.4.4. Inhibition kinetics of α-amylase and α-glucosidase {#s0070}

Mode of inhibition of AgNps on enzyme activity was determined as described by [@b0015]. Briefly, fixed amounts of both α-amylase and α-glucosidase were incubated with increasing concentrations of starch and pNPG, respectively at 37 ± 2 °C for 20 min, in the absence and presence of the AgNps extracts (3 mg/ml). Reactions were terminated and absorption measurements carried out as mentioned above. The amount of products, reducing sugars as maltose and p-nitrophenol respectively, that are liberated were determined from the corresponding standard curve and then converted to reaction velocities.

2.5. Antibacterial screening {#s0075}
----------------------------

Mueller Hinton agar was seeded with appropriate well mixed overnight nutrient broth culture of each test microorganism to 0.5 McFarland turbidity standard: *Staphylococcus aureus* (ATCC 25923), *Escherichia coli* (ATCC 26922), *Pseudomonas aeruginosa* (ATCC 27853), *Salmonella* species (UKQC 9990), and *Bacillus subtilis* (ATCC 6051), respectively. 1 × 10^6^ colony forming units (CFU) per millilitre was used, by streaking evenly on to the surface of the medium with a sterile cotton swab to allow for even growth. Wells were cut from the agar plates using a sterile bore ([@b0295]). The wells were loaded with 30 μl for each sample using a sterile micropipette allowing a 10 min diffusion time. Vancomycin 30 μg, Gentamycin 10 μg discs, and 1 mM AgNO~3~ were used as positive controls and distilled water served as the negative control. The plates were incubated at 37 ± 2 °C for 24 h thereafter the plates were examined for any clearing zones around the walls and/or discs. The zones of inhibition were measured in mm using a measuring ruler and compared to the controls. This experiment was carried out six times for confirmation and statistical analysis.

2.6. Statistical analysis {#s0080}
-------------------------

The statistical analysis of data was expressed as mean ± standard error of the mean (SEM). The antibacterial study were analysed using the Wilcoxon Signed Ranks test and the antidiabetic study were analysed by means of a one-way and a two-way Anova and Bonferroni multiple comparison post test using the GraphPad Prism® 5.03 software.

3. Results {#s0085}
==========

3.1. GC--MS studies {#s0090}
-------------------

The phytochemical examination of *O. basilicum* typically includes the presence of tannins, steroids, terpenoids, flavonoids, cardiac glycosides ([@b0070], [@b0325]) squalene, phenol,2-methoxy-4-(1-propenyl)-\[Isoeugenol\], caryophyllene oxide, nonadecane, decane,2,9-dimethyl-, linolenic acid ethyl ester, hexadecanoic acid ethyl ester ([@b0130]), linalool, 1,8-cineole, borneol, eugenol, and α-caryophyllene ([@b0325]). Whereas in previous studies from a comparative perspective, the crude extract composition of *O. sanctum* appears to be marginally different, with a varied concentration of alkaloids, tannins, glycosides, saponins, terpenoids, tri-terpenoids, steroids, flavonoids ([@b0135], [@b0310]), ascorbic acid, carotene, polyphenols, fatty acids and sitosterol, sugars (xylose and polysaccharides), pectins, sesquiterpene and monoterpenes. Some of these phytochemicals are believed to be responsible for the high therapeutic potency of *O. sanctum* including, hypoglycaemic and antibacterial effects of ([@b0095], [@b0135]), anticataleptic, antitoxic, immunomodulatory, analgesic, cardioprotective and anticancer properties ([@b0035]).

In the present study, the chemical composition of the leaf extract of *O. basilicum* and *O. sanctum* (L.) was determined via GC--MS analysis using Shimadzu GC-2010 Plus with GCMS-QP2010SE equipped with a split/splitless capillary injection port. The capillary column used was a GL Sciences InertCap 5MS/Sil Length 30 mm, I.D. 0.25 mm, file thickness 0.25 μm. Chemical constituents were identified after comparison with those available in the computer library (NIST) attached to the GC--MS instrument. The organic compounds that were identified in *O. basilicum* leaf extract include: cyclohexanol; menthol; hexanedioic acid/adipic acid; 3,7,11,15-tetramethyl-2-hexadecen-1-ol; 13-methyl-14-pentadecene-1,13-diol; and terpenes such as squalene and phytol consistent with those previously published ([@b0180]). The GC--MS report for *O. sanctum* recorded phenolics, terpenes (linalool, beta-terpeneol, phytol, squalene), terpenoids (camphor), and various amine compounds, similar to previous reports ([@b0165]) ([Tables S1 and S2](#s0150){ref-type="sec"}). In the present study, the variability in chemical composition of the two plants could depend on the selection of extractant, extraction techniques ([@b0075]), climatic and geographical conditions ([@b0275]).

3.2. Characterization tests of the AgNps {#s0095}
----------------------------------------

### 3.2.1. UV--Visible studies {#s0100}

The synthesis of AgNps with various leaf extracts was successful; the nanometallic silver exhibited a well-defined absorption peak at 438 nm from *O. basilicum*, 439 nm for *O. sanctum*, and 433 nm from the combination extract. The consequent colour changes were observed from a light yellow to a brown colour ([Fig. 1](#f0005){ref-type="fig"}(A--C)). The interaction of Nps with biomolecules of *O. basilicum* leaf, *O. sanctum* leaf and in combination *O. sanctum* + *O. basilicum*, respectively validated the reduction of Ag^+^ ions to Ag^0^ by the secondary plant metabolites that are in turn oxidized to other species. Even though the mechanism has not been adequately elucidated, it is components such as polyols, amines, phenolics, flavonoids, and water-soluble heterocyclic compounds as well as other factors such as reducing sugars, proteins and other oxido-reductive labile metabolites present in the *O. basilicum* and *O. sanctum* leaf extracts that possess the ability to reduce Ag^+^ ions to Ag^0^. Similar UV--Vis spectrum results have been ascertained in the case of the stabilizing effect of natural biological extracts in the formation of stable metal Nps ([@b0245], [@b0255], [@b0160]).Figure 1UV--Visible absorption spectra of AgNps synthesized using (A) aq. *O. basilicum* leaf extract (B) aq. *O. sanctum* leaf extract (C) aq. *O. sanctum* in combination with *O. basilicum* leaf extract at different reaction times. Progressive colour change indicating the formation of AgNps over a 36 h period; from L → R AgNps formation over 12 → 24 → 36 h.

### 3.2.2. TEM analysis {#s0105}

The results obtained from the TEM monograph indicated the size and shape properties of the formed AgNps derived from *O. sanctum*, *O. basilicum* respectively, and in combination. Representative TEM images indicated that most of the particles were near spherically shaped and were predominantly monodispersed ([@b0010]). The particles exhibited a distribution of mean size ± standard deviation (SD), at a size range of 17.0 ± 8.94 nm for *O. basilicum* AgNps, 15.0 ± 12.34 nm for *O. sanctum* AgNps and 17.0 ± 8.44 nm for the combination *O. sanctum* + *O. basilicum* AgNps ([Figs. S1 and S2](#s0150){ref-type="sec"}). These results show that it is possible to prepare stable AgNps of size less than 17 nm by varying the ratio of AgNO~3~, *O. sanctum*, *O. basilicum* and use a combination of extract solutions from two different plants as a means for effective production of stable AgNps.

### 3.2.3. SEM--EDX analysis {#s0110}

The crystalline nature of AgNps and nanosize was confirmed by the SEM and EDX patterns. The SEM image showed relatively spherical shaped Nps formed with a diameter range of 100 nm. The EDX revealed a strong signal in the silver region at five different areas for all three samples, and thus confirmed the formation of AgNps. In addition, an observed spectral signal for oxygen (O) and other elements indicated the extracellular organic moieties (originating from *O. basilicum* and *O. sanctum* leaf extracts, respectively) that were adsorbed on the surface or in the vicinity of the metal nanoparticles or may originate from the biomolecules that were bound to the surface of the Nps. Peaks for sulphur (S), phosphorus (P) and nitrogen (N) correspond to the protein capping over the AgNps. However, certain elements come from the artefact during sample preparation. Peaks for carbon (C) originate from the grid used ([Figs. S3 and S4](#s0150){ref-type="sec"}).

### 3.2.4. Zeta Potential and DLS analysis {#s0115}

DLS measurement presented the size distribution of the Nps with an average size of 56.81 nm and stability for the AgNps *O. basilicum* at −19.8 mV; for AgNps *O. sanctum* at size of 467.4 nm and stability at −23.3 mV; and for AgNps *O. sanctum* + *O. basilicum* at size of 155.1 nm and stability at −24.3 mV in zeta potential analysis. Unavoidably, the particle size obtained from TEM, SEM--EDX and DLS is different, due to the varying principles used for measurement, similar observations were reported for AgNps prepared from *Melia azedarach* ([@b0245]). However, a stable size dispersion of particles was evident from the zeta potential, a zeta potential higher than +30 mV or lesser than −30 mV is indicative of a stable system ([@b0160]) ([Fig. S5](#s0150){ref-type="sec"}). Many reports have proposed that surface active molecules can stabilize the Nps and that the reaction of the metal ions is possibly facilitated by reducing sugars and or terpenoids ([@b9000]). In addition, organic molecules such as carotenoids, vitamins, minerals, amino acids, sterols, glycosides, alkaloids, flavonoids, terpenes and phenolics can also act as surface active molecules responsible for stability and formation of the AgNps ([@b0125]).

### 3.2.5. FTIR studies {#s0120}

FTIR was used to identify any potential biomolecules, present in the leaf extract (*O. sanctum* and *O. basilicum*), which are responsible for reducing Ag^+^ ions to Ag^0^. FTIR spectra of the crude aq. extract and AgNps derived from *O. basilicum* showed a decrease in stretching frequency from 3300.21 to 3297.12 cm^−1^ suggesting an OH functional group. Furthermore a shift from 1634.78 to 1635.67 cm^−1^ is assigned to the carbonyl C000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000O stretch, whereas peaks at 1217 cm^−1^ can be attributed to the ether linkages ([Fig. 2](#f0010){ref-type="fig"}(A)). For *O. sanctum* similar results obtained to that of *O. basilicum* with the exception of CO bond that was identified ([Fig. 2](#f0010){ref-type="fig"}(B)). The dual properties of AgNps synthesized from *O. basilicum* and *O. sanctum* were evident with the addition of C--H stretch ([Fig. 2](#f0010){ref-type="fig"}(C)). It is thus speculated that the conversion of C--OH biomolecules to CO group may be responsible for the reduction of Ag^+^ to Ag^0^. The absorption peak at 1635.48--1635.82 cm^−1^ for AgNps (*O. sanctum*) may be assigned to the amide I bond or proteins arising due to carbonyl stretch, suggesting that the proteins are interacting with biosynthesized Nps and that their secondary structure was not affected during reaction with Ag^+^ ions or after binding with AgNps. These IR spectroscopic studies confirmed that a carbonyl group of amino acid residues has a strong binding ability with the metal suggesting the formation of a layer covering the metal Nps and acting as a capping agent to prevent agglomeration and providing stability to the medium. The range of 3250--3400 cm^−1^, that is, amide region from the earlier literature states that binding as well as stabilization takes place by free amide groups present in proteinaceous substances used for synthesis ([@b0175]). Supported by the GC--MS results, N--H amide compounds were identified from *O. sanctum* leaf extract, these results confirm the presence of possible proteins acting as reducing and stabilizing agents, namely: Cis-11-Eicosenamide, 8-Methyl-6-nonenamide, 13-Docosenamide, (13z)-N-(\[(13z)-13-Docosenoylamino\]methyl)-13-docosenamide. Thus, a mechanism for the biosynthesis of AgNps can be elucidated using amide compounds identified from *O. sanctum* extracts which acts as a natural reducing agent ([Scheme 1](#f0015){ref-type="fig"}(A)). Peak at 3100--3300 cm^−1^ is assigned to O--H stretching in alcohols and phenolic compounds, the results are similar to previous reports ([@b0290]). Previous reports indicate peaks for *Ocimum* sp. are more characteristic of eugenol, linalool and terpenes that are abundant in these plant extracts ([@b0250]). Depending on the above observation, it can be assumed that the stabilization and formation of AgNps are achieved by the phenolic as well as aromatic compounds present in the *O. sanctum* and *O. basilicum* extracts ([Scheme 1](#f0015){ref-type="fig"}(B)).Figure 2FTIR spectra of AgNps synthesized using (A) aq. *O. basilicum* leaf extract (B) aq. *O. sanctum* leaf extract (C) aq. *O. sanctum* in combination with *O. basilicum* leaf extract.Scheme 1Proposed mechanism was elucidated using (A) phenolic compounds present in abundance in *Ocimum* sp. for the rapid formation of medicinal AgNps (B) amide compounds typically identified in *O. sanctum* leaf extracts for the rapid formation of medicinal AgNps.

3.3. Inhibitory effect of AgNps on α-amylase and α-glucosidase activity {#s0125}
-----------------------------------------------------------------------

[Table 1](#t0005){ref-type="table"} shows the percentage inhibition and IC~50~ values obtained for the AgNps synthesized from *O. basilicum*, *O. sanctum* and their respective crude extracts. AgNps synthesized from *O. sanctum* and *O. basilicum*, respectively demonstrated high inhibitory activity against α-amylase than acarbose, however, the crude *O. sanctum* and *O. basilicum* extracts demonstrated greater inhibition compared to acarbose ([Fig. S6](#s0150){ref-type="sec"}). [Table 2](#t0010){ref-type="table"} shows the inhibition against *B. stearothermophilus* α-glucosidase of the AgNps synthesized from *O. sanctum* (89.31 ± 5.319%) and *O. basilicum* (79.74 ± 9.51%) indicating the activity was far greater compared to that of acarbose and their respective crude extracts. However, the combination derived AgNps extract yielded the lowest inhibitory activity (29.03 ± 15.92%) against α-glucosidase compared to acarbose, *p*-value 0.05 ([Fig. S7](#s0150){ref-type="sec"}). The enzyme kinetics revealed inhibition in a competitive manner for AgNps derived from *O. sanctum* leaf extract on α-amylase (*K~m~* is increased, whereas *V*~max~ remain the same). These findings indicate that some of the α-amylase inhibitory components in AgNps derived from *O. sanctum* aq. extract may be structural analogues of the substrate that compete for binding at the active site of α-amylase. The case of AgNps derived from *O. basilicum* leaf extract on α-amylase was found to be uncompetitive (*K~m~* is decreased and *V*~max~ is decreased) this suggests that some of the α-amylase inhibitory components in this AgNps bind only to the enzyme-substrate complex and may distort the active site. Both *O. sanctum* and *O. basilicum* derived AgNps appeared to be in competitive inhibition on α-glucosidase activity. In view of the α-glucosidase effects of AgNps synthesized from *O. sanctum* and *O. basilicum* this may be comparable to the effect of the standard α-amylase and α-glucosidase inhibitor, acarbose, which competitively and reversibly inhibits α-glucosidase enzyme from the intestine and the pancreas ([@b0155]). Due to the fact that the EtOH (70%) leaf *O. basilicum* and *O. sanctum* extracts showed highest percentage inhibition against α-glucosidase their modes of inhibition were determined. The natural *O. sanctum* extract appeared to be a close competitive inhibitor and *O. basilicum* natural extract appeared to show inhibition in an uncompetitive manner against α-glucosidase activity. As a result, the catalytic hydrolysis reaction using *in vitro* α-amylase and α-glucosidase as a means of evaluation ([@b0040]) suggested a varied MOA presented in the reaction mechanism by the crude phytocompound--enzyme mixture in comparison to the metal-Np-enzyme composite, which may be due to the variation in the two enzymes structural and catalytic properties.Table 1Inhibitory effect of AgNps and crude extracts on α-amylase activity.Samples*In vitro* α-amylase inhibition % 3 mg/ml (AgNps) 2 mg/ml (crude extracts)*p*-valueIC~50~ (mg/ml)\
^a^0.05--1.6 mg/ml\
^b^0.002--2 mg/ml\
^c^0.003--3 mg/mlAcarbose48.27 ± 1.79\<0.00010.022AgNps OS59.57 ± 3.72^∗^0.0040.070^a^AgNps OB59.79 ± 6.910.0130.016^a^AgNps OS + OB54.94 ± 6.560.0140.169^a^OS Aq. dist. (leaf)61.23 ± 5.240.0070.028^b^OS 60% EtOH (leaf)66.33 ± 4.26^∗^0.0040.021^b^OS 70% EtOH (leaf)64.14 ± 13.470.0180.017^c^OB Aq. dist. (leaf)61.23 ± 5.240.0070.029^b^OB 60% EtOH (leaf)55.13 ± 9.170.0270.033^b^OB 70% EtOH (leaf)55.81 ± 7.860.0190.009^c^[^1]Table 2Inhibitory effect of AgNps and crude extracts on α-glucosidase activity.Samples*In vitro* α-glucosidase inhibition %\
^a^0.2 mg/ml\
^b^0.3 mg/ml*p*-valueIC~50~ (mg/ml)\
^c^0.0003--3 mg/ml\
^d^0.0002--0.2 mg/mlAcarbose73.75 ± 12.860.0020.001AgNps OB^b^79.74 ± 9.510.0141.533^c^AgNps OS^b^89.31 ± 5.32\<0.00010.009^c^AgNps OS + OB^b^29.03 ± 15.92--NIOS Aq. dist. (leaf)^b^62.25 ± 11.250.0120.089^c^OS 60% EtOH (leaf)^a^49.50 ± 2.180.00022.566^d^OS 70% EtOH (leaf)^b^66.00 ± 7.800.0040.288^c^OB Aq. dist. (leaf)^b^34.75 ± 3.705^∗^0.00310.55^c^OB 60% EtOH (leaf)^b^50.50 ± 3.5940.0010.002^c^OB 70% EtOH (leaf)^b^69.89 ± 6.871\<0.00010.007^c^[^2]

3.4. Antimicrobial activity {#s0130}
---------------------------

[Table 3](#t0015){ref-type="table"} depicts the antibacterial activity of AgNps *O. sanctum* at (6.333 ± 1.174) against *S. aureus*, *p*-value 0.713 and inhibition for AgNps *O. basilicum* (3.667 ± 0.333), *p*-value 0.026, whereas, combination extracts showed the lowest antibacterial activity compared to Vancomycin (6.000 ± 0.000), *p*-value 0.027. Antimicrobial properties of AgNps *O. sanctum* were observed against *E. coli* (6.000 ± 1.033), *p*-value 0.518, followed by *P. aeruginosa* (3.167 ± 0.601), *p*-value 0.038, and the least was noticed against *Salmonella* sp. (2.000 ± 0.000), *p*-value 0.014 as shown in [Figs. S8--S10](#s0150){ref-type="sec"}, a similar report was obtained on *O. sanctum* AgNps synthesized via the green route, and were found to be highly toxic against clinically isolated bacterial species ([@b0270]). The highest antibacterial activity was observed against *E. coli* (4.167 ± 0.792), *p*-value 0.339 using AgNps synthesized from *O. basilicum*, and the lowest was observed against *P. aeruginosa* (2.667 ± 0.333), *p*-value 0.026, similar to results obtained in previous research ([@b0295]). However, no activity was observed against *Salmonella* sp. The combined extracts AgNps displayed the lowest antimicrobial properties and the crude 10% aq. extracts showed no inhibitory activity against the test strains. The wide range of particle sizes, specifically 3--17 nm with a narrow size distribution were obtained from the two different plants. Nps with sizes \<15 nm exhibited in the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) tests, for 1 in 2 dilution of AgNps *O. sanctum* against *Salmonella* sp. was 66.67% no growth (×4 plates) and 33.33% growth when compared to the 100% growth for the water control. MIC and MBC for 1 in 4 dilution of AgNps *O. sanctum* against *Salmonella* sp. were 50% no growth (×3 plates), and 50% growth when compared to the 100% growth for the water control, *p*-value summary 0.045. MIC and MBC for 1 in 2 dilution AgNps *O. sanctum* against *S. aureus* were 100% no growth (×6 plates) and 0% growth when compared to the 100% growth for the water control. However, 17 nm size particles for *O. basilicum* leaf synthesized AgNps against *S. aureus* showed 83.33% no growth (×5 plates) and 16.67% growth; and combination extracts (*O. sanctum* + *O. basilicum*) synthesized AgNps represented 50% no growth (×3 plates) and 50% growth when compared to 100% growth for the water control, *p*-value 0.0003 ([Fig. S11](#s0150){ref-type="sec"}).Table 3Zones of inhibition in (mm) for AgNps against the various bacterial test strains.Samples*B. subtilis*[a](#tblfn1){ref-type="table-fn"}*E. coli*[a](#tblfn1){ref-type="table-fn"}*P. aeruginosa*[a](#tblfn1){ref-type="table-fn"}*Salmonella* sp. [a](#tblfn1){ref-type="table-fn"}*S. aureus*[a](#tblfn1){ref-type="table-fn"}*S. aureus*[b](#tblfn2){ref-type="table-fn"}AgNps OS2.000 ± 0.0006.000 ± 1.0333.167 ± 0.6012.000 ± 0.0006.333 ± 1.1742.667 ± 0.333AgNps OB2.000 ± 0.0004.167 ± 0.7922.667 ± 0.333NI3.667 ± 0.3331.333 ± 0.333AgNps OS + OB3.000 ± 0.0001.500 ± 0.2242.000 ± 0.365NI2.167 ± 0.4771.000 ± 0.000OS 10% aq. extracts.NINININININIOB 10% aq. extracts.NINININININIOS + OB 10% aq. extractsNINININININIControl (1 mM AgNO~3~)2.000 ± 0.0001.500 ± 0.2242.000 ± 0.0001.667 ± 0.2112.000 ± 1.0952.333 ± 0.333+Control (Gentamycin 10 μg)10.000 ± 0.0005.000 ± 0.0006.000 ± 0.0004.000 ± 0.000----+Control (Vancomycin 30 μg)--------6.000 ± 0.0003.000 ± 0.000−Control (distilled water)NINININININI[^3][^4][^5]

4. Discussion {#s0135}
=============

Current global interest in the use of eco-friendly and economical resources propels the use of highly acclaimed medical plants to direct the green synthesis of metal Np entities, that possess diverse biological and catalytic properties. Furthermore, the rationale for the synthesis of AgNps was twofold: (1) to combine AgNps (higher bioactive properties) with a natural *Ocimum* sp. extracts (chemically inert and less toxicity), and (2) increase the surface phenomenon in the reduction reaction (higher surface to volume ratio) to achieve greater biological activity. Stable spherical colloidal AgNps were synthesized using antidiabetic and antimicrobial potent *O. basilicum* and *O. sanctum* as the reducing agent as opposed to high thermal conversion energy, or hazardous solvents. Inert, spherical Nps with a size range of 3--25 nm were characterized by UV--Vis spectroscopy, TEM, SEM--EDX and stability confirmed by DLS and zeta potential. In addition, important medicinal functional groups were confirmed via FTIR and GC--MS. Inhibitors of α-amylase and intestinal α-glucosidase enzymes retard the rate of carbohydrate digestion, thereby provides an alternative therapeutic option for modulation of postprandial hyperglycaemia (PPHG) ([@b0305]). In diabetic patients, a sustained reduction of hyperglycaemia is shown to decrease the risk of developing microvascular and macrovascular diseases and their associated complications ([@b0235]). The results obtained in this study are coherent with previous studies confirming the hypoglycaemic properties of natural *O. basilicum* ([@b0070]) and *O. sanctum* extracts ([@b0050]) prepared using a variety of extraction techniques (thermal/high energy conversion), hazardous solvents and high dosages. Both the plants exhibited higher inhibitory activity towards the enzymes as opposed to many other hypoglycaemic plants reported in previous studies ([@b0220]). In comparison, first time *in vitro* hypoglycaemic assessment of AgNps synthesized via the green protocol using *Ocimum* sp. indicates higher bioactive properties. The enhanced activity of AgNps obtained in the α-glucosidase assessment may be due to their high surface area to volume ratio, thus increasing the surface area phenomenon (promoting the electron transfer reaction) and may increase the pharmacokinetics from a biological view. The effects of oral hypoglycaemic drugs depend on a number of pharmacokinetic factors such as absorption, metabolism and excretion, and the actions of drugs begin inside the cells, it is believed that AgNps small size are easily carried across the cell membrane by transport proteins and may exhibit prolonged effects in bio-systems ([@b0140]). Therefore, it is suggested colloidal AgNps to be used as effective nanomedicine for treatment of DM; however, further *in vivo* pharmacokinetic studies are encouraged. Diabetic induced infections are currently increasing at an alarming rate, adding to the associated complications, worsening the effects of the disease and are rapidly draining health care resources ([@b0265], [@b0320]). Diabetic peripheral neuropathy (polyneuropathy) among all of the other associated co-morbid diabetic conditions is reported to be the prime factor involved in the bacterial aetiology of diabetic foot trauma and ulceration. Upon the initial exposure of a bacterial infection, it is associated with delayed recognition of symptoms combined with poor peripheral circulation that delays healing and encourages opportunistic infection ([@b0285]). Infectious agents can lead to the worst outcomes in diabetic patients as it can cause gangrene, which may lead to amputation of the foot or limb and even death if prompt treatment is not ensured. In addition, polymicrobial infections caused by a combination of bacteria such as *Staphylococcus*, *E. coli*, *P. aeruginosa*, and/or MRSA in diabetic foot infections are increasingly becoming a problem, especially in previously hospitalized patients ([@b0110]). In the current study, the green synthesis of AgNps capped with important plant phytochemicals such as phenolics ([@b0195]), flavonoids, carbohydrates, tannins, quinones and other important bioactive compounds ([@b0185]) contribute to the enhanced properties of the phytochemical mixture with metal Nps. This is especially significant to overcome antimicrobial resistance with greater beneficial outcomes at a lower toxicity to the human body ([@b0185]). The bactericidal properties of the most exploited AgNps of typically \<20 nm in diameter can be explained by the release of reactive and charged silver ions from particles ([@b0270]), causing bacterial cell damage in two ways. Either by adhering to the bacterial cell wall, causing disruption in cell-wall permeability and cellular respiration ([@b0290]), or causing damage by interacting with phosphorus and sulphur containing compounds such as deoxyribonucleic acid (DNA) and proteins ([@b0170]).

Various AgNps synthesized from *Ocimum* sp. displayed significant antibacterial potency at very low concentration. The small sizes (\<15 nm) of the Nps play a central role in the interaction and penetration with the bacterial cells and exhibited higher antimicrobial activity than larger Nps ([@b0210]). In addition, indicates a clear distinction in the destruction of Gram negative and Gram positive bacteria specifically the charge they carry, and the variation in cell wall composition ([@b0215]). Previous reports indicate that the electrostatic attraction between negatively charged bacterial cells and positively charged Nps or vice versa is crucial for the bactericidal activity of Nps ([@b0300]). In the current study, AgNps are negatively charged confirmed by the zeta potential analysis, therefore the mechanism of interaction between these particles and the outer membrane of Gram positive bacteria that consist of lipoteichoic acid and teichoic acid showed higher inhibition against *S. aureus*. In comparison, Gram negative bacteria that consist of lipopolysaccharide and an outer membrane remains unclear, however, it would appear that despite the negative surface charge on *E. coli*, *P. aeruginosa*, and *Salmonella* sp. the AgNps may react with the building elements of the bacterial membrane, causing structural changes, degradation and finally cell death ([@b0190]). However they may be limited by different physiochemical properties of plant molecules capping the surface of the metal Np. Thus, a dose dependent effect of AgNps (in the size range of \<15 nm) on the Gram negative bacteria is recommended for further studies. Furthermore, coupling the inherent medicinal properties of *Ocimum* sp. with that of AgNps proved to be beneficial to minimize the dose needed to be administered for total antimicrobial reduction against diabetic related pathogens *S. aureus*, *E. coli*, *P. aeruginosa*, *B. subtilis*, and *Salmonella* sp.

5. Conclusion {#s0140}
=============

In this study, an environmentally benign, straightforward, facile, and medicinally active phytochemical route synthesized colloidal AgNps from the leaves of indigenous plants found in abundance in SA, *O. basilicum*, *O. sanctum* respectively, and for the first time in combination in an attempt to develop antihyperglycaemic agents that elicit a euglycaemic response. These AgNps were characterized by the following techniques, viz., GC--MS, FTIR, UV--Vis spectroscopy, SEM--EDX, TEM, DLS, and zeta potential. The bio-derived AgNps showed excellent inhibitory enzymatic activity/antibacterial properties than their respective crude extract and the standard controls. These observations, plus evidence of their potent antioxidant activity from phenolic rich plants such as *Ocimum* sp. indicate the value of further studies. Thus, synthesis of AgNps based drugs with greater targeted activity coalesced with medicinal phytochemicals derived from the leaves of *O. basilicum* and *O. sanctum* or combined may result in unprecedented opportunities directed at the discovery of a cheaper and more beneficial therapy for hyperglycaemia, and prevention of diabetic induced complications such peripheral neuropathy that predisposes bacterial infections.

Appendix A. Supplementary data {#s0150}
==============================

Supplementary dataThis file contains supplementary figures and tables.
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[^1]: Results are expressed as mean ± SEM; *N* = 3; *p* \< 0.05, *p*-value summary ^\*^ vs control; OS = *O. sanctum*, OB = *O. basilicum*.

[^2]: Results are expressed as mean ± SEM; *N* = 3; *p* \< 0.05, *p*-value summary ^\*^ vs control; OS = *O. sanctum*; OB = *O. basilicum*; NI = No Inhibition.

[^3]: Results are expressed as mean inhibition ± SEM, *N* = 6; OS = *O. sanctum*, OB = *O. basilicum*; NI = No Inhibition.

[^4]: Grouping variable: 100 μl of bacteria per plate.

[^5]: Grouping variable: 200 μl of bacteria per plate.
